2nd Canadian Peptide and Protein Community Virtual Meeting
Emerging Peptide and Protein Science
16 Dec 2024
Peptide, Protein, Biopolymer
- Go to the Sessions
- Event Details
Our 2nd virtual CPPC symposium aims to unite students and leading researchers from academia and industry at the cutting edge of peptide and protein science. This one-day free on-line virtual event will feature oral and poster presentations from leading scientists and emerging young investigators (students and post-doctoral fellows) shaping the future of peptide and protein science.
Welcome from the Chairs
Peptides and proteins are extraordinary natural biopolymers. Inspiring various fields of contemporary research, peptides and proteins serve as components of a variety of medicines, catalysts, materials, cosmetics, and agricultural products. Our 2nd virtual symposium is designed to bring together students and leading researchers at the cutting edge of peptide and protein science. With a broad focus and the intent to promote the visibility of emerging scientists and young investigators, this one-day event will feature leaders in the field of peptides and proteins exploring various domains to improve basic knowledge and enhance quality of life.
Keynote Speakers
Department of Chemistry, University of Copenhagen
Design and solid phase synthesis of peptide and protein catalysts.
Dr. Morten Meldal is a unique influencer on methods used in peptide and combinatorial chemistry. Rewarded the Nobel Prize in Chemistry in 2022, his specialties span combinatorial, click and polymer chemistry, organic synthesis, automation in synthesis, artificial receptors, enzyme activity, nano and cellular assays, biomolecular recognition, and immunology, as well as nano-scale spectrometric, spectroscopic, and encoding techniques.
Invited Speakers
Department of Chemistry, Dalhousie University
Harnessing thioamide reactivity to access heterocycle-containing peptides
Dr. Carlie Charron is a young investigator who since joining the chemistry faculty of Dalhousie University in 2022, has launched an interdisciplinary research program focusing on cytotoxic natural peptide products and three-dimensional therapeutic peptide architectures.
School of Science, School of Life Sciences, Westlake Laboratory, Westlake University
Micropolarity governs the structural organization of biomolecular condensates
Professor of Chemistry and Cell Biology at Westlake University, Dr. Xin Zhang is focused on developing enabling methods for quantitatively reporting on the physicochemical changes of biomolecules during processes of phase separation and aggregation.
Centre for Research on Biomolecular Interactions, Department of Chemistry, York University
Engineering Chimeric Protein Systems Toward Versatile Manipulation of the Genome in Living Cells
Dr. Bill Kim is a young investigator who since joining the chemistry faculty of York University, has been developing bio-engineering tools for understanding proteins implicated in normal and pathogenic biological processes.
Event Chairs
Canadian Peptide and Protein Community,
Department of Chemistry, Université de Montréal
Professor William D. Lubell studies medicinal chemistry and peptide science by the innovation of peptides and peptidomimetics that target and modulate biologically relevant receptors for drug discovery (www.wdlubellgroup.com). Co-author of >250 scientific publications, former Associate Editor of Organic Letters (2005-2018), editorial board member of journals in the biomedical sciences, and innovator of intellectual property used to launch start-up companies, Lubell received the 2013 Canadian Society for Chemistry Bernard Belleau and the 2018 Teva Canada Limited Biological and Medicinal Chemistry Lectureship Awards. Forging collaborations with biochemists, pharmacologists and physicians, his efforts are critical in drug discovery teams developing interventions to treat Alzheimer’s disease, premature birth, an unmet-medical need with the highest cost per patient, and age-related macular degeneration, the leading cause of adult blindness. Originator of Molecules of Life (www.moleculesoflife.ca) and co-author of the Molecular Marvels of Superheroes Series, Lubell explores experiential education techniques to teach the public about science.
Canadian Peptide and Protein Community,
Faculté de pharmacie de l’Université Laval,
Centre de recherche du CHU de Québec-Université Laval,
Canadian Peptide and Protein Community,
Department of Chemistry, University of Toronto
Canadian Peptide and Protein Community,
Chemistry Department, Western University
Dr. Len Luyt received his Ph.D. in Chemistry from Western University and subsequently undertook a post-doctoral fellowship with Prof. John Katzenellenbogen at the University of Illinois, Urbana-Champaign. He then led a research team as a Senior Medicinal Chemist with the pharmaceutical company Bayer-Schering. Dr. Luyt joined Western University in 2005 as a faculty member with appointments in the Departments of Chemistry, Oncology and Medical Imaging, and was promoted to full Professor in 2020. The research program of Dr. Luyt spans from basic chemistry activities, looking at novel methods of incorporating metal complexes into peptide structures, through to applied research, investigating new peptide therapeutics and molecular imaging agents for novel cancer targets.
Canadian Peptide and Protein Community,
Department of Chemistry, University of British Columbia
Canadian Peptide and Protein Community,
Department of Chemistry, University of Toronto
Canadian Peptide and Protein Community,
Department of Chemistry, Carleton University
Dr. David Sabatino performs research interfacing nucleic acid and peptide chemical biology. Aiming to develop novel anti-cancer agents, Dr. Sabatino is exploring original synthetic RNA- and peptide-based agents for gene and immune therapy. Mentor of over 60 students, co-author of more than 40 peer-reviewed scientific publications, conference proceedings, patents and a book chapter, Dr. Sabatino has delivered over 70 conference presentations at regional, national, and international meetings. The Sabatino laboratory has benefited from support from federal government funding agencies in the USA (NIH/NCI) and Canada (NSERC and CFI) to preform research oriented on the development of anti-cancer treatment strategies. Nominated Researcher of the Year at Seton Hall University in 2019, Dr. Sabatino was recruited to the Department of Chemistry at Carleton University in 2022.
Canadian Peptide and Protein Community,
Département de chimie, Université du Québec à Montréal
Canadian Peptide and Protein Community,
School of Biomedical Engineering, Faculty of Medicine, University of Prince Edward Island
Canadian Peptide and Protein Community,
Armand-Frappier Santé Biotechnologie Research Centre
Canadian Peptide and Protein Community,
BridGene Biosciences, San Jose, CA.
Instructions for Authors
Instructions for Authors
Submission
Registration for this conference is FREE.
Submissions will be accepted online. Authors may submit their work by registering at www.sciforum.net and using the "Start New Submission" function once they are logged into the system. Please make other comments about contributing author’s status: post-doc, graduate student, or other in the process of submission.
- Scholars interested in participating in the conference can submit their abstract (200-word limit) on this website until 5 November 2024.
- The Chairs will pre-evaluate, based on the submitted abstract, whether a contribution will be included in the 2nd Canadian Peptide and Protein Community Virtual Symposium. Authors will be notified by 15 November 2024 about the acceptance decision regarding their abstract.
- If the abstract is accepted, the author will be invited to prepare a PowerPoint (PPT, oral presentation) or poster presentation by the submission deadline of 1 December 2024.
Presentation Slides
Authors are encouraged to prepare a presentation in PowerPoint or similar software, to be displayed online along with the manuscript. Slides, if available, will be directly displayed on the website using Sciforum.net’s proprietary slides viewer. Slides can be prepared in the same way as for any traditional conference where research results can be presented. Slides should be converted to the PDF format before submission so that our process can easily and automatically convert them for online display.
CPPC oral presentation ppt template.pptx
Presentation of Posters
Posters will be available on this website during and after the event. As with papers presented at conferences, participants will be able to ask questions and make comments about the posters. Posters will be available online on this website during and after the virtual conference.
Posters should include the following:
- Title (with authors and affiliations);
• Introduction/objectives/aims;
• Methods;
• Results;
• Conclusion;
• References;
• Acknowledgments;
• Contact information.
There are no uniform format requirements for posters, which can be prepared in vertical or horizontal orientation.
NOTE: In the system, "manuscript PDF" is showing to be mandatory, which means as selected oral/poster presentation, you should prepare your PPT/poster in a PDF format and upload it there.
Potential Conflicts of Interest
It is the authors’ responsibility to identify and declare any personal circumstances or interests that may be perceived as inappropriately influencing the representation or interpretation of clinical research. If there are no conflicts, please state here “The authors declare no conflicts of interest”. This should be conveyed in a separate “Conflicts of Interest” statement preceding the “Acknowledgments” and “References” sections at the end of the manuscript. Financial support for the study must be fully disclosed under the “Acknowledgments” section.
Copyright
MDPI, the publisher of the Sciforum.net platform, is an open access publisher. We believe that authors should retain the copyright to their scholarly works. Hence, by submitting an abstarct/poster or other files to this conference, you retain the copyright of your paper, but you grant MDPI the non-exclusive right to publish this paper online on the Sciforum.net platform. This means you can easily submit your paper to any scientific journal at a later stage and transfer the copyright to its publisher (if required by that publisher).
List of accepted submissions (2)
Id | Title | Authors | Poster PDF | ||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
sciforum-107926 |
The [(bathophenanthroline)3:Fe2+] complex as an aromatic non-polymeric medium for purification of human lactoferrin |
N/A |
Show Abstract |
||||||||||||||||||||||||||||||||||||||
We describe a non-chromatographic, ligand-free platform for the efficient purification of recombinant human lactoferrin. The platform consists of a [metal:chelator] complex precipitate in the presence of osmotically active polyethylene glycol 6000 . Purification is achieved in three stages. Following formation of the complex, LF is captured under neutral conditions by the aggregated complexes (Step I), a washing step follows (Step II) and then, (Step III) LF is extracted in pure form with 100 mM tribasic Na citrate buffer (pH 7). Of the four complexes investigated, [bathophenanthroline (batho)3:Fe2+] was determined to be the most efficient. LF is recovered with high yield (~90%) and purity (≥97%, by SDS polyacrylamide gel electrophoresis ) from an artificial contamination background comprising E. coli lysate proteins. Purified LF is demonstrated to be monomeric by dynamic light scattering ; to preserve its native secondary structure by circular dichroism spectroscopy; and, as apo-LF, to efficiently inhibit bacterial growth. Process yield is not |
|||||||||||||||||||||||||||||||||||||||||
sciforum-106418 | Aggregation of silver nanoparticles in presence of bovine serum albumin |
Paula Sofia Rivero ,
|
N/A |
Show Abstract |
|||||||||||||||||||||||||||||||||||||
Nanotechnologies have garnered significant attention in the scientific community due to their applications in various areas of medicine. In particular, silvernanoparticles(Ag-NPs) are noteworthy for their antibacterial and surface plasmonic properties, which depend on their shape anisotropy. Understanding the interactions of Ag-NPs with biomolecules in biological systems is essential for the safe use of new treatments involving these materials. For this reason, we study serum albumin(BSA), the most abundant protein in blood, which plays key roles such as regulating pH, solubilizing certain drugs, and transporting pharmaceutical agents. Examining the behavior of nanoparticles with albumin (Ag-NPs/BSA) can provide valuable insights into their pharmacological effects.[1] In this work, we've confirmed that the presence of prism-shapedAg-NPs and sphericalAg-NPs induces changes in the protein structure, that include aggregation. The technologies used include FourierTransformInfraredSpectroscopy(FT-IR), Small-AngleX-RayScattering(SAXS), and Transmission Electron Microscopy(TEM) to study these interactions FTIR results have shown slight differences between the BSA spectrum and the Ag-NPs spectrum in band shape, indicating minimal interaction. In contrast, XAS results have revealed strong attractive interactions leading to aggregation. Finally, TEM confirmed the aggregation of nanoparticles in the presence of BSA. [2] [1] http://dx.doi.org/10.1016/j.molliq.2016.02.103 |
Event Awards
Event Awards
To acknowledge the support of the conference’s esteemed authors and recognize their outstanding scientific accomplishments in the field of biomolecular and molecular science, we are pleased to launch the Best Oral Presentation Awards and the Best Poster Presentation Awards, sponsored by Biomedicines and International Journal of Molecular Sciences. Eight winners will be selected, and each winner will receive a cash award of USD 100. Winners will be announced after the sessions.
The Awards
Number of Awards Available: 2
The prize for each of the awards will consist of USD 100 (two will be awarded to graduate students and post-doctoral fellows).
Number of Awards Available: 6
The prize for each of the awards will consist of USD 100 (six will be awarded to graduate students and post-doctoral fellows).
Terms and Conditions:
- If the short abstract is accepted, PPT or posters must be submitted.
- Originality / Novelty of the paper
- Significance of Content
- Scientific Soundness
- Interest to the readers
First Meeting Group Photo
DESIGN, SYNTHESIS AND ANALYSIS. Design, Synthesis and Analysis of Peptide and Protein Structures
POSTERS. Poster Session
13h00 - 15h00 EST = 2 hours
Poster Session in Breakout Rooms
Posters will be selected from submitted abstracts and judged for prizes.